
James Riddle, MCSE, CIP, CPIA, CRQM
With 25+ years’ experience providing support to the clinical research community, James Riddle helps sponsors, CROs, and research sites advance clinical research with a mission to improve human health. His expertise includes developing and operationalizing processes for maximum efficiency, client satisfaction, and participant protection; development and implementation of technology solutions; and efficient, compliant operation of large clinical research review programs. Prior to Advarra, Riddle held leadership roles at two major central IRBs and served as a senior leader within the research oversight office at the Fred Hutchinson Cancer Research Center. He is also a member of CTTI, NWABR, SASI, and PRIM&R.
Latest Posts by James Riddle

Ways to Streamline Informed Consent Process in Clinical Trial Startup
At a busy research site, a clinical trial is ready to launch — but it’s...
Read More...
Understanding the Impact of the New EU Artificial Intelligence Act on Clinical Research
Artificial intelligence (AI) has taken the world by storm – and regulators are paying attention....
Read More...
The Value of Continuity: Program-level Data Safety Monitoring Boards
In the realm of pharmaceutical development, ensuring the safety and efficacy of new treatments is...
Read More...
Understanding FDA’s 2024 Draft Guidance on DMCs
The FDA's 2024 draft guidance emphasizes the critical role of independent DMCs in clinical trials,...
Read More...
DSMB Best Practices and Behind the Scenes Insights
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and...
Read More...
What is a Data Monitoring Committee?
DMCs play a vital role in clinical trials by independently reviewing interim data for safety...
Read More...
Multiple Dynamic Endpoints and the Role of Endpoint Adjudication Committees in Clinical Trials
How do you know your experimental therapy is working? Sometimes, it can be as simple...
Read More...
Privacy Regulations Impact on Global Clinical Trial Endpoint Adjudication
New privacy regulations seem to form every few months, especially with individual U.S. states adopting...
Read More...
Unpacking IRB Innovations for Decentralized Clinical Trials
In the blink of an eye, the world has gone digital. So many tasks which...
Read More...
What Goes into a Charter for DSMB or Endpoint Adjudication?
Learn the essentials of creating a robust charter for DMCs and EACs—an indispensable tool for...
Read More...